progression-free survival

You have access
Prognostic Nutritional Index Is Superior to Neutrophil-to-lymphocyte Ratio as a Prognostic Marker in Metastatic Breast Cancer Patients Treated With Eribulin
TAKAAKI OBA, KAZUMA MAENO, MAYU ONO, TOKIKO ITO, TOSHIHARU KANAI and KEN-ICHI ITO

Anticancer Research January 2021, 41 (1) 445-452; DOI: https://doi.org/10.21873/anticanres.14794
You have access
Continuous Administration of Bevacizumab After Disease Progression in Recurrent Ovarian Cancer: A Retrospective Observational Study
TERUMI TANIGAWA, MAKI MATODA, MAKIKO OMI, YOICHI AOKI, SACHIHO NETSU, HIDETAKA NOMURA, SANSHIRO OKAMOTO, KOHEI OMATSU, MAYU YUNOKAWA, HIROYUKI KANAO and NOBUHIRO TAKESHIMA

Anticancer Research September 2020, 40 (9) 5285-5290; DOI: https://doi.org/10.21873/anticanres.14533
You have access
The Impact of Antibiotics on Prognosis of Metastatic Renal Cell Carcinoma in Japanese Patients Treated With Immune Checkpoint Inhibitors
KOSUKE UEDA, SATORU YONEKURA, NAOYUKI OGASAWARA, YOSHIHIRO MATSUNAGA, RYUJI HOSHINO, HIROFUMI KUROSE, KATSUAKI CHIKUI, KEIICHIRO UEMURA, MAKOTO NAKIRI, KIYOAKI NISHIHARA, MITSUNORI MATSUO, SHIGETAKA SUEKANE and TSUKASA IGAWA

Anticancer Research November 2019, 39 (11) 6265-6271; DOI: https://doi.org/10.21873/anticanres.13836
You have access
Baseline Tumor Size as a Predictive and Prognostic Factor of Immune Checkpoint Inhibitor Therapy for Non-small Cell Lung Cancer
MASAHIRO KATSURADA, TATSUYA NAGANO, MOTOKO TACHIHARA, TATSUNORI KIRIU, KOICHI FURUKAWA, KIYOKO KOYAMA, TAKEHIRO OTOSHI, REINA SEKIYA, DAISUKE HAZAMA, DAISUKE TAMURA, KYOSUKE NAKATA, NAOKO KATSURADA, MASATSUGU YAMAMOTO, KAZUYUKI KOBAYASHI and YOSHIHIRO NISHIMURA

Anticancer Research February 2019, 39 (2) 815-825; DOI: https://doi.org/10.21873/anticanres.13180
You have access
Chronic Inflammation as a Potential Predictive Factor of Nivolumab Therapy in Non-small Cell Lung Cancer
MARTIN SVATON, MILADA ZEMANOVA, JANA SKRICKOVA, LENKA JAKUBIKOVA, VITEZSLAV KOLEK, JURAJ KULTAN, LEONA KOUBKOVA, ALZBETA BEJCKOVA, FRANTISEK SALAJKA, MICHAL HRNCIARIK, BOHUSLAV MELICHAR, DAVID VRANA, MAREK KONECNY, RENATA CHLOUPKOVA and MILOS PESEK

Anticancer Research December 2018, 38 (12) 6771-6782; DOI: https://doi.org/10.21873/anticanres.13048
You have access
Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma
MATTEO SANTONI, FRANCESCO PIVA, UGO DE GIORGI, ALESSANDRA MOSCA, UMBERTO BASSO, DANIELE SANTINI, SEBASTIANO BUTI, CRISTIAN LOLLI, CARLO TERRONE, MARCO MARUZZO, MICHELE IULIANI, MELISSA BERSANELLI, ALESSANDRO CONTI, ROBERTA MAZZUCCHELLI, RODOLFO MONTIRONI, LUCIANO BURATTINI and ROSSANA BERARDI

Anticancer Research October 2018, 38 (10) 5773-5782; DOI: https://doi.org/10.21873/anticanres.12916
You have access
Prognostic Significance of Neutrophil–to–lymphocyte Ratio in the Framework of the 8th TNM Edition for Breast Cancer
PATRIZIA FERRONI, MARIO ROSELLI, ORESTE C. BUONOMO, ANTONELLA SPILA, ILARIA PORTARENA, ANASTASIA LAUDISI, MARIA G. VALENTE, SILVANA P. PIRILLO, LUCIO FORTUNATO, LEOPOLDO COSTARELLI, FRANCESCO CAVALIERE and FIORELLA GUADAGNI

Anticancer Research August 2018, 38 (8) 4705-4712; DOI: https://doi.org/10.21873/anticanres.12777
You have access
Relationship and Predictive Role of the Dual Expression of FGFR and IL-8 in Metastatic Renal Cell Carcinoma Treated with Targeted Agents
ROBERTO IACOVELLI, MICHELE DE TURSI, CLAUDIA MOSILLO, ANTONIO CIARDI, CONSIGLIA CARELLA, CLARA NATOLI, GIUSEPPE NASO and ENRICO CORTESI

Anticancer Research May 2018, 38 (5) 3105-3110;
You have access
A Proposal for Progression-Free Survival Assessment in Patients with Early Progressive Cancer
TAKANORI TANASE, CHIKUMA HAMADA, TAKAYUKI YOSHINO and ATSUSHI OHTSU

Anticancer Research October 2017, 37 (10) 5851-5855;
You have access
Predictive Factors for Poor Progression-free Survival in Patients with Non-small Cell Lung Cancer Treated with Nivolumab
YOSHIHIKO TANIGUCHI, AKIHIRO TAMIYA, SYUN-ICHI ISA, KENJI NAKAHAMA, KYOICHI OKISHIO, TAKAYUKI SHIROYAMA, HIDEKAZU SUZUKI, TAKAKO INOUE, MOTOHIRO TAMIYA, TOMONORI HIRASHIMA, FUMIO IMAMURA and SHINJI ATAGI

Anticancer Research October 2017, 37 (10) 5857-5862;

Main menu

User menu

Search

progression-free survival

Pages